UnitedHealth Group Inc (UNH) Shares Sold by Nan Shan Life Insurance Co. Ltd.
Nan Shan Life Insurance Co. Ltd. trimmed its position in UnitedHealth Group Inc (NYSE:UNH) by 40.0% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 120,000 shares of the healthcare conglomerate’s stock after selling 80,000 shares during the period. Nan Shan Life Insurance Co. Ltd.’s holdings in UnitedHealth Group were worth $29,441,000 at the end of the most recent reporting period.
A number of other hedge funds have also recently bought and sold shares of UNH. Summit Trail Advisors LLC boosted its holdings in shares of UnitedHealth Group by 19,286.4% during the 1st quarter. Summit Trail Advisors LLC now owns 6,228,065 shares of the healthcare conglomerate’s stock worth $6,228,000 after purchasing an additional 6,195,939 shares during the last quarter. FMR LLC boosted its holdings in shares of UnitedHealth Group by 5.1% during the 2nd quarter. FMR LLC now owns 61,622,355 shares of the healthcare conglomerate’s stock worth $15,118,428,000 after purchasing an additional 2,981,233 shares during the last quarter. Bank of Montreal Can acquired a new position in shares of UnitedHealth Group during the 2nd quarter worth approximately $381,555,000. Janus Henderson Group PLC boosted its holdings in shares of UnitedHealth Group by 61.7% during the 2nd quarter. Janus Henderson Group PLC now owns 3,525,090 shares of the healthcare conglomerate’s stock worth $864,869,000 after purchasing an additional 1,345,083 shares during the last quarter. Finally, Chevy Chase Trust Holdings Inc. acquired a new position in shares of UnitedHealth Group during the 2nd quarter worth approximately $248,898,000. Institutional investors own 85.31% of the company’s stock.
Several research analysts have recently weighed in on the company. Morgan Stanley boosted their target price on UnitedHealth Group from $278.00 to $305.00 and gave the stock an “overweight” rating in a report on Wednesday, September 5th. Citigroup cut UnitedHealth Group from a “buy” rating to a “neutral” rating and set a $288.00 target price on the stock. in a report on Monday, September 10th. Cowen assumed coverage on UnitedHealth Group in a report on Monday. They set an “outperform” rating and a $308.00 target price on the stock. Cantor Fitzgerald restated a “buy” rating and set a $300.00 target price on shares of UnitedHealth Group in a report on Thursday, August 9th. Finally, ValuEngine cut UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Tuesday, September 11th. Two analysts have rated the stock with a hold rating and twenty-two have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average target price of $274.05.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, July 17th. The healthcare conglomerate reported $3.14 EPS for the quarter, beating analysts’ consensus estimates of $3.04 by $0.10. UnitedHealth Group had a return on equity of 22.79% and a net margin of 5.55%. The firm had revenue of $56.09 billion for the quarter, compared to analysts’ expectations of $56.10 billion. During the same period in the prior year, the firm posted $2.46 earnings per share. The firm’s quarterly revenue was up 12.1% on a year-over-year basis. analysts anticipate that UnitedHealth Group Inc will post 12.72 EPS for the current year.
The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 18th. Shareholders of record on Friday, September 7th will be given a $0.90 dividend. This represents a $3.60 dividend on an annualized basis and a yield of 1.36%. The ex-dividend date of this dividend is Thursday, September 6th. UnitedHealth Group’s payout ratio is 35.75%.
UnitedHealth Group announced that its Board of Directors has initiated a share repurchase plan on Wednesday, June 6th that permits the company to repurchase 100,000,000 outstanding shares. This repurchase authorization permits the healthcare conglomerate to buy shares of its stock through open market purchases. Shares repurchase plans are typically an indication that the company’s leadership believes its shares are undervalued.
In other UnitedHealth Group news, CEO Steven H. Nelson sold 8,142 shares of the business’s stock in a transaction that occurred on Thursday, September 13th. The stock was sold at an average price of $265.00, for a total value of $2,157,630.00. Following the sale, the chief executive officer now owns 22,496 shares of the company’s stock, valued at $5,961,440. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Kenneth Irwin Shine sold 177 shares of the business’s stock in a transaction that occurred on Wednesday, July 18th. The shares were sold at an average price of $255.72, for a total value of $45,262.44. Following the completion of the sale, the director now directly owns 29,053 shares in the company, valued at approximately $7,429,433.16. The disclosure for this sale can be found here. In the last three months, insiders sold 94,745 shares of company stock worth $24,995,290. 0.87% of the stock is owned by corporate insiders.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.